These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29670789)

  • 1. Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis.
    Lautredou CC; Hardin JS; Chancellor JR; Uwaydat SH; Ellabban AA; Sallam AB
    Case Rep Ophthalmol Med; 2018; 2018():7419823. PubMed ID: 29670789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis.
    Dutta Majumder P; Mayilvakanam L; Palker AH; Sridharan S; Biswas J
    Indian J Ophthalmol; 2019 Sep; 67(9):1487-1490. PubMed ID: 31436209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature.
    Sacchi M; Villani E; Gilardoni F; Nucci P
    Clin Ophthalmol; 2014; 8():1253-7. PubMed ID: 25061272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for the Treatment of Cystoid Macular Edema in a Patient With Syphilitic Uveitis and HIV Infection.
    Pappaterra-Rodriguez MC; Amaral C; Requejo Figueroa GA; Ayala Rodríguez SC; De Jesús Rodríguez E; Alejandro KC; Oliver AL
    Cureus; 2022 Dec; 14(12):e32865. PubMed ID: 36699774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
    Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
    Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
    Bernard Y; Bonnin N; Farguette F; Chiambaretta F
    J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia.
    Cachero Rodríguez JM; Artaraz J; Imaz N; Fonollosa A
    J Ophthalmic Inflamm Infect; 2024 May; 14(1):19. PubMed ID: 38700565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
    Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
    Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.
    Burgos-Blasco B; Hernandez-Ruiz S; Lopez-Guajardo L; Donate-Lopez J
    Am J Ophthalmol Case Rep; 2020 Jun; 18():100653. PubMed ID: 32190783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
    Lei S; Lam WC
    Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cystoid macular edema secondary to chronic non-infectious intermediate uveitis with an intraocular dexamethasone implant.
    Rossetto JD; Nascimento H; Fernandes DD; Belfort R; Muccioli C
    Arq Bras Oftalmol; 2015; 78(3):190-3. PubMed ID: 26222112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
    Ahn SJ; Kim KE; Woo SJ; Park KH
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.
    Sahin O; Ziaei A
    Retina; 2014 Jul; 34(7):1451-9. PubMed ID: 24531737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema.
    Al Zamil WM
    Saudi J Ophthalmol; 2015; 29(2):130-4. PubMed ID: 25892932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal dexamethasone implant in patients with persistent macular edema of variable etiologies.
    Sorkin N; Loewenstein A; Habot-Wilner Z; Goldstein M
    Ophthalmologica; 2014; 232(2):83-91. PubMed ID: 24942067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].
    Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants.
    Brynskov T; Laugesen CS; Halborg J; Kemp H; Sørensen TL
    Clin Ophthalmol; 2013; 7():1171-4. PubMed ID: 23818753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.